Prioritization of patients with liver cancer within the MELD system

被引：5

作者：

Roberts, JP

机构：

[1] Univ Calif San Francisco, Liver Transplant Program, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Kidney Transplant Program, San Francisco, CA 94143 USA

来源：

LIVER TRANSPLANTATION | 2002年 / 8卷 / 04期

关键词：

D O I：

10.1053/jlts.2002.32622

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：329 / 330

页数：2

共 4 条

[1]

Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma [J].

Cheng, SJ ;

Freeman, RB ;

Wong, JB .

LIVER TRANSPLANTATION, 2002, 8 (04) :323-328

[2]

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts [J].

Malinchoc, M ;

Kamath, PS ;

Gordon, FD ;

Peine, CJ ;

Rank, J ;

ter Borg, PCJ .

HEPATOLOGY, 2000, 31 (04) :864-871

[3]

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma [J].

Muto, Y ;

Moriwaki, H ;

Ninomiya, M ;

Adachi, S ;

Saito, A ;

Takasaki, KT ;

Tanaka, T ;

Tsurumi, K ;

Okuno, M ;

Tomita, E ;

Nakamura, T ;

Kojima, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) :1561-1567

[4]

Yao F, 2001, HEPATOLOGY, V34, p174A

← 1 →